buprenorphine implant
Selected indexed studies
- Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management. (BMJ Evid Based Med, 2020) [PMID:32094200]
- Probuphine® (buprenorphine implant): a promising candidate in opioid dependence. (Ther Adv Psychopharmacol, 2017) [PMID:28348732]
- Medication Treatment of Opioid Use Disorder. (Biol Psychiatry, 2020) [PMID:31420089]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management. (2020) pubmed
- Probuphine® (buprenorphine implant): a promising candidate in opioid dependence. (2017) pubmed
- Medication Treatment of Opioid Use Disorder. (2020) pubmed
- New developments in managing opioid addiction: impact of a subdermal buprenorphine implant. (2017) pubmed
- The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews. (2023) pubmed
- Comparison of naltrexone implant and oral buprenorphine-naloxone in the treatment of opiate use disorder. (2022) pubmed
- Patients' perspectives on buprenorphine subcutaneous implant: a case series. (2024) pubmed
- Compacted solid implant formulations for long-term buprenorphine delivery. (2026) pubmed
- A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls. (2017) pubmed
- Buprenorphine implant for opioid addiction. (2012) pubmed